[{"Assets_0_Q2_USD":"40946500000.0","CIK":"59478","CommonStockDividendsPerShareCashPaid_1_Q2_USD":"0.52","CommonStockDividendsPerShareCashPaid_2_Q2_USD":"1.04","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.96","EarningsPerShareBasic_2_Q2_USD":"0.85","EarningsPerShareDiluted_1_Q2_USD":"0.95","EarningsPerShareDiluted_2_Q2_USD":"0.85","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q2_USD":"68900000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"1991000000.0","NetIncomeLoss_1_Q2_USD":"1008000000.0","NetIncomeLoss_2_Q2_USD":"897200000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_2_Q2_USD":"1096100000.0","RevenuesConverted_1_Q2_USD":"5824300000.0","RevenuesConverted_2_Q2_USD":"11052600000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"14169700000.0","StockholdersEquity_0_Q2_USD":"14100800000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"1057100000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"1057500000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"1055000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"1055600000.0","filed":"20170728","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"LILLY ELI & CO","period":"20170630","qtrs":"0","uom":"USD"}]